Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sciclone Pharmaceut (SCLN)

Sciclone Pharmaceut (SCLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sciclone Pharmaceut 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404 USA

www.sciclone.com P: 650-358-3456

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. They have focused their current product development and commercial activities on the following diseases: hepatitis C, hepatocellular carcinoma, malignant melanoma, hepatitis B, HIV, drug-resistant tuberculosis, cystic fibrosis and others.

Key Statistics

Overview:

Market Capitalization, $K 581,918
Shares Outstanding, K 52,190
% of Insider Shareholders 5.16%
% of Institutional Shareholders 72.80%
Annual Net Income, $ 30,730 K
Last Quarter Sales, $ 44,520 K
Last Quarter Net Income, $ 12,190 K
3-Year Return 43.87%
5-Year Return 88.98%
5-Year Revenue Growth 19.80%
5-Year Earnings Growth 29.09%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/08/17
Earnings Per Share ttm 0.91
EPS Growth vs. Prev Qtr -10.34%
EPS Growth vs. Prev Year 44.44%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SCLN Ratios

Ratio
Price/Earnings ttm 12.25
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 21.10%
Return-on-Assets % 19.03%
Profit Margin % 19.19%
Debt/Equity 0.00
Price/Sales 3.63
Price/Cash Flow 14.83
Price/Book 2.31
Book Value/Share 4.82
Interest Coverage 0.00
60-Month Beta 1.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar